Background: Primary CNS melanoma is a rare neoplasm of the brain. Nevus of Ota is an area of macular, melanocytic pigmentation of the sclera and skin around the eye. Association between intracranial melanocytic neoplasms and Nevus of Ota has previously been described in case reports. The two lesions tend to occur ipsilaterally and in Caucasian patients. We present the first documented case of a primary malignant CNS melanoma contralateral to a Nevus of Ota in an African-American patient.
. It is a manifestation of the same melanocytic proliferation that leads to primary CNS melanocytic lesions. It is thought to occur due to abnormal migration of melanocytes, which prematurely arrest in the dermis rather than at the usual dermal-epidermal junction (Hino, 2005) . Nevus of Ota is an extremely rare lesion, but when it does occur, it most commonly affects the Asian population with a strong female propensity. It is a lesion with a characteristic gross diagnostic appearance. Therefore, skin biopsy is often not needed for diagnosis, though it is sometimes performed for academic interest.
There is a known association between melanocytic intracranial lesions and the Nevus of Ota (Arunkumar, 2001; Balmaceda, 1983; Botticelli, 1983; Clarke, 1998; Enriquez, 1973; Gomez-Gonzalez, 1965; Hartmann, 1989; Hino, 2005; Horsey, 1980; Kabuto, 1980; Kojima, 1959; Piercecchi-Marti, 2002; Rahimi-Movaghar, 2003; Rivers, 2001; Rutten, 2005; Sagar, 1983; Sang, 1977/; Theunissen, 1993; Willis, 1967) . These reports have most commonly consisted of intracranial melanoma or melanocytoma ipsilateral to the Nevus of Ota in Caucasian patients. We present a unique case of primary malignant CNS melanoma located contralateral to a Nevus of Ota in an African-American female.
Case Report
A 32-year-old African-American female initially presented with intermittent episodes of left-sided numbness involving her face, arm, and leg that were associated with mild head "pressure." She had no associated weakness, nausea, vomiting, vision change, or bowel/bladder incontinence. She also had no generalized convulsions. These episodes would last several seconds and would resolve spontaneously. When she suffered her third such episode, she sought medical attention.
The patient had no significant past medical or surgical history. Specifically, she had no history of renal disease or hypertension. The patient worked as an attorney and did not drink alcohol, smoke cigarettes, or use any illicit drugs. Specifically, she did not have any history of cocaine or amphetamine use. Her family history revealed no evidence of neurological disease.
General physical exam revealed the presence of a large area of hyperpigmentation involving the left side of her face, especially around the eye and upper cheek (Figure 1 ). The lesion was a heterogeneous, macular region that was black in color. It was significantly darker than her normal skin pigment. This lesion has been present since birth and has not shown any significant change in size or character in her adult life. Her neurological exam at presentation was normal.
She underwent a CT (computed tomography) scan of the brain with and without contrast that revealed a right www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 4, No. 1; 2015 fronto-temporal intracranial hemorrhage (2.0 cm x 2.5 cm x 2.0 cm) with a rim of surrounding vasogenic edema (Figure 2 ). CT images show a hemorrhagic intraparenchymal mass in the right frontal and temporal lobes, surrounding the sylvian fissure. Note vasogenic edema surrounding the lesion.
Given the hemorrhagic nature of the lesion and unremarkable past medical history of the patient, the decision was made to perform a diagnostic 4-vessel cerebral angiogram to exclude an underlying arteriovenous malformation or aneurysm. No vascular abnormalities were found. The patient remained asymptomatic during her hospitalization and was neurologically intact on examination. The decision was made to allow the patient to recover from the intracranial hemorrhage with planned repeat imaging two months later. She was also placed on phenytoin for seizure prophylaxis.
MRI (magnetic resonance imaging) of the brain with and without gadolinium ( Figure 3 ) was performed two months later and revealed that the hemorrhagic lesion had actually expanded in size and still contained a significant amount of surrounding edema. This further confirmed the suspicion that there was a tumor associated with this hemorrhagic area. The decision was made to proceed with surgical resection of the lesion to both relieve the mass effect and to obtain a definitive diagnosis.
A right frontotemporal craniotomy was performed using frameless stereotactic navigation. Once the right frontal and temporal lobes were exposed, we noted that there were diffuse punctuate foci of black hyperpigmentation throughout the subarachnoid space. This was noted in all the sulcal spaces exposed. The mass was approached by a transsylvian corridor using the microscope. The tumor was black and moderately firm on the outer surface. There were areas of hemorrhage within the mass, but separate areas of abnormal tissue without hemorrhage were also identified and resected. Gross total resection was performed, and the mass was sent for pathological identification. Where unobscured by pigment, the nuclei were highly pleomorphic, with high nuclear/cytoplasmic ratios and numerous prominent nucleoli, many of which were eosinophilic. Few mitotic figures were noted. Bleached sections allowed better appreciation of the hypercellularity, nuclear pleomorphism with prominent eosinophilic nucleoli, and necrosis ( Figure 5 ). Focal perivascular infiltration of tumor was noted in adjacent neuropil. Pathological diagnosis was consistent with primary central nervous system malignant melanoma. The patient is undergoing adjuvant radiation therapy.
Given the association of Nevus of Ota with pigmented ocular lesions (typically affecting the sclera, cornea, and conjunctiva), a complete ophthalmological examination was performed. No abnormal findings were found.
Discussion
Nevus of Ota, also referred to as oculodermal melanocytosis or nevus fuscoceruleus opthalmomaxillaris, is a hyperpigmented lesion usually involving the distribution of the first and second branches of the trigeminal nerve. Thus, it commonly affects the skin around the eye and on the cheek. It was first described by Hulke in 1861 in association with malignant melanoma of the sclera. In 1939, Ota described a series of 26 cases in Japan (Ota, 1939) . It occurs either congenitally (60%) or has onset at puberty (40%). It is usually a unilateral, macular lesion that varies in color from blue to black with heterogeneity often seen within the same lesion. It typically gets darker during adolescence and persists into adulthood. It most commonly affects the Asian population with a strong female propensity (4:1). Histopathologically, it is a patch-like area of dermal melanocytic pigmentation. An association exists with pigmented lesions involving the eye, especially the sclera, episclera, and conjunctiva. These ocular manifestations are most commonly noted in African-Americans and Asians and are overall seen in about 50-60% of cases. Nevus of Ota has also been reported in association with Takayasu's arteritis (Reinke, 1974) , Klippel-Trenaunay syndrome (Furukawa, 1970) , and Type 1 neurofibromatosis (Clarke, 1998) . Given its www.ccsenet.org/cco Cancer and Clinical Oncology Vol. 4, No. 1; 2015 unique gross appearance and distribution, biopsy is rarely indicated for diagnostic purposes.
Nevus of Ota and intracranial melanocytic lesions share a similar embryologic origin. Melanoblasts develop from neural crest origin and are seen as early as the 10 th week of fetal life. They differentiate into melanocytes, which are fusiform elements with the ability to produce melanin. These normally migrate to skin, meninges, ocular structures, and the inner ear (Botticelli, 1983) . In the skin, melanocytes are normally found at the dermal/epidermal junction. Occasionally, due to an error in migration, some melanocytes become arrested in the dermis. Due to this migration anomaly, a variety of dermatopathology may occur, including a Mongolion spot, cellular blue nevus, and a Nevus of Ota.
In the CNS, melanocytes are specifically located in the pia, which is the neural crest component of the meninges. They are diffusely distributed in the CNS, but do have a higher concentration in the ventral medulla oblongata and upper cervical spinal cord. Neoplastic transformation of these melanocytes can lead to a spectrum of primary CNS melanoctyic tumors. These range from melanocytoma (which are benign lesions with an excellent prognosis) to malignant melanoma (with aggressive histologic features and a poor prognosis) (Rahimi-Movaghar, 2003) . These are extremely rare lesions with less than 200 reported cases.
The neuroimaging appearance of melanoma is quite variable, depending on the melanin content and also on the presence of hemorrhage, which is often seen with both primary and metastatic malignant melanoma. On non-enhanced CT scan, melanomas are often hyperdense, and they enhance fairly homogenously with intravenous contrast. They are typically hyperintense on T1 weighted MRI and hypointense on T2 weighted MRI. Angiography is rarely performed, but does reveal an occasional blush due to pial blood supply.
Light microscopic findings of melanoma include sheets of polygonal and elongated cells with round or oval hyperchromic nuclei and eosinophilic cytoplasm that contains brown, granular pigment. Cells are often fusiform in shape and are sometimes arranged in lobules. Similar to other neuro-oncological disease, frequent mitoses, hypercellularity, nuclear pleomorphism, and perivascular infiltration are characteristic of malignant neoplasms that would not be seen in a melanocytoma. Electron microscopy, though rarely performed, reveals a lack of tight junctions and melanosomes that are in various stages of development. There are also no desmosomes or interdigitating cytoplasmic processes, in contrast to meningioma.
Immunohistochemistry evaluation is often performed if the melanotic lesion is dural based in order to distinguish it from meningioma. Melanomas stain positively for HMB-45 (anti-melanosomal antibody), S-100, and vimentin and are reactive with epithelial membrane antigen (which is often positive in meningioma).
An association between primary CNS melanoma and Nevus of Ota has been demonstrated in the literature. Fourteen cases have been previously reported (Table 1) . This is not surprising given the similar pathophysiology of the two lesions. The majority of these cases (58%) have involved lesions that were dural-based. Our case is especially interesting in two separate regards. First, the intracranial melanoma was located contralateral to the Nevus of Ota. This has only been reported twice before in the literature. Second, our patient is of African-American descent. The simultaneous occurrence of primary CNS melanoma and contralateral Nevus of Ota has not previously been documented in an African-American patient. Despite the fact that these lesions are both rare, one should consider primary CNS melanoma in the differential diagnosis in a patient with Nevus of Ota who presents with an intracranial mass lesion.
Conclusion
Primary CNS melanoma and a Nevus of Ota have been rarely reported to occur simultaneously. We present a unique example of this occurrence in an African-American female. It is made more unique because the intracranial lesion is contralateral to the Nevus of Ota. Primary CNS melanoma should be considered in the differential diagnosis in a patient with Nevus of Ota and an intracranial mass.
